Study validates diagnostic assay for Asian cancers

A Singapore research team of clinicians and scientists has validated a cancer diagnostic assay designed with Asian-centric biomarkers that aims to enable early diagnosis and timely treatment delivery. These findings, published in the journal Frontiers in Molecular Biosciences on September 21, 2022, supports the assay's use for making critical diagnoses and well-informed therapeutic decisions for Asian prevalent cancers.

source https://medicalxpress.com/news/2022-10-validates-diagnostic-assay-asian-cancers.html